WhiteOak Capital Pharma and Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-1.02%)Nav, as on 09-01-2026

  • Previous Nav

  • Net Change on 09-01-2026

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
BSE SENSEX - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 -2.15 21.66 14.26 1.82 8,264.71
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 -0.05 26.84 16.74 1.86 6,455.55
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 -1.38 21.67 14.59 1.93 2,770.84
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 -3.42 21.66 14.30 2.10 1,310.50
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 -3.07 23.52 14.03 2.27 1,101.63

Fund Holdings as on 31-December-2025

  • Sun Pharmaceutical Industries Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Max Healthcare Institute Limited

  • Laurus Labs Limited

  • Fortis Healthcare Limited

  • Lupin Limited

  • Divi's Laboratories Limited

  • Cipla Limited

  • Clearing Corporation of India Ltd

  • Alkem Laboratories Limited

  • Neuland Laboratories Limited

  • Krishna Institute Of Medical Sciences Limited

  • Ajanta Pharma Limited

  • Sai Life Sciences Limited

  • Shaily Engineering Plastics Limited

  • Vijaya Diagnostic Centre Limited

  • Abbott India Limited

  • Apollo Hospitals Enterprise Limited

  • Narayana Hrudayalaya Limited

  • Pfizer Limited

  • AstraZeneca Pharma India Limited

  • Emcure Pharmaceuticals Limited

  • Kovai Medical Center and Hospital Limited

  • Eris Lifesciences Limited

  • Zota Health Care Limited

  • Thyrocare Technologies Limited

  • Acutaas Chemicals Limited

  • Sudeep Pharma Limited

  • Navin Fluorine International Limited

  • Poly Medicure Limited

  • Strides Pharma Science Limited

  • Dr.Agarwals Eye Hospital Limited

  • Aether Industries Limited

  • Jupiter Life Line Hospitals Limited

  • Supriya Lifescience Limited

  • 91 Days Tbill (MD 12/03/2026)

  • Anthem Biosciences Limited

  • Shilpa Medicare Limited

  • Corona Remedies Limited

  • Dr. Reddy's Laboratories Limited

  • 91 Days Tbill (MD 15/01/2026)

  • 182 Days Tbill (MD 19/02/2026)

  • Orchid Pharma Limited

  • Piramal Pharma Limited

  • 182 Days Tbill (MD 12/02/2026)

  • 364 Days Tbill (MD 19/03/2026)

  • 91 Days Tbill (MD 19/02/2026)

  • 182 Days Tbill (MD 19/03/2026)

  • 91 Days Tbill (MD 08/01/2026)

  • 364 Days Tbill (MD 05/02/2026)

  • 91 Days Tbill (MD 26/02/2026)

  • Net Receivables / (Payables)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Chemicals

  • Plastic Products

  • Trading

  • Medical Equipment/Supplies/Accessories

View More

Fund Manager

  • Cash

  • Equity

  • Sovereign

View More

About WhiteOak Capital Pharma and Healthcare Fund

Scheme Analysis

WhiteOak Capital Pharma and Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to WhiteOak Capital Mutual Fund. It was launched on 06-Feb-2024 and currently has an AUM of ₹508.73 crore. WhiteOak Capital Pharma and Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of WhiteOak Capital Pharma and Healthcare Fund ended down ₹-0.14(-1.02%)yesterday to ₹13.745.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The WhiteOak Capital Pharma and Healthcare Fund is managed by Piyush Baranwal and Ramesh Mantri.

Fund House Contact

Unit No. B4, 6th Floor, Cnergy, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025

022-6918 7607
022 69187643